左氧氟沙星: 一种Bacterial Top II抑制剂药物,由Johnson & Johnson (美国强生公司)公司最早进行研发,目前全球最高研发状态为批准上市,作用机制: Bacterial Top II抑制剂(细菌拓扑异构酶II抑制剂),治疗领域: 感染,遗传病与畸形,消化系统疾病,在研适应症: 外耳炎,中耳炎,
8 Debt-equity choices, R&D investment and market timing Lewis, Craig M.; Tan, Yongxian JOURNAL OF FINANCIAL ECONOMICS 2016 9 The impacts of political uncertainty on asset prices: Evidence from the Bo scandal in China Liu, Laura Xiaolei; Shu, Haibing; Wei, K. C. John JOURNAL OF FINANCIAL...
2The information role of audit opinions in debt contractingChen, Peter F.; He, Shaohua; Ma, Zhiming; Stice, DerraldJOURNAL OF ACCOUNTING & ECONOMICS2016 3Financial Reporting Quality of Chinese Reverse Merger Firms: The Reverse Merger Effect or the Weak Country Effect?Chen, Kun-Chih; Cheng, Qi...